Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …
tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis …
Breast cancer: current molecular therapeutic targets and new players
S Nagini - Anti-Cancer Agents in Medicinal Chemistry …, 2017 - ingentaconnect.com
Breast cancer is the most common cancer and the most frequent cause of cancer death
among women worldwide. Breast cancer is a complex, heterogeneous disease classified …
among women worldwide. Breast cancer is a complex, heterogeneous disease classified …
Rational design of multitarget-directed ligands: strategies and emerging paradigms
J Zhou, X Jiang, S He, H Jiang, F Feng… - Journal of medicinal …, 2019 - ACS Publications
Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit
satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation …
satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation …
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
XJ Liu, HC Zhao, SJ Hou, HJ Zhang, L Cheng… - Bioorganic …, 2023 - Elsevier
Vascular epidermal growth factor receptor-2 (VEGFR-2), as an important tyrosine
transmembrane protein, plays an important role in regulating endothelial cell proliferation …
transmembrane protein, plays an important role in regulating endothelial cell proliferation …
Designing multi-targeted agents: An emerging anticancer drug discovery paradigm
R Fu, Y Sun, W Sheng, D Liao - European journal of medicinal chemistry, 2017 - Elsevier
The dominant paradigm in drug discovery is to design ligands with maximum selectivity to
act on individual drug targets. With the target-based approach, many new chemical entities …
act on individual drug targets. With the target-based approach, many new chemical entities …
Estrogen receptor ligands: a review (2013–2015)
S Farzaneh, A Zarghi - Scientia pharmaceutica, 2016 - mdpi.com
Estrogen receptors (ERs) are a group of compounds named for their importance in both
menstrual and estrous reproductive cycles. They are involved in the regulation of various …
menstrual and estrous reproductive cycles. They are involved in the regulation of various …
Pd (II)-catalyzed annulation reactions of epoxides with benzamides to synthesize isoquinolones
Epoxides as alkylating reagents are unprecedentedly applied in Pd (II)-catalyzed C–H
alkylation and oxidative annulation of substituted benzamides to synthesize isoquinolones …
alkylation and oxidative annulation of substituted benzamides to synthesize isoquinolones …
Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer
S Xiong, K Song, H Xiang, G Luo - European Journal of Medicinal …, 2024 - Elsevier
Estrogen receptor alpha (ERα), a nuclear transcription factor, is a well-validated therapeutic
target for more than 70% of all breast cancers (BCs). Antagonizing ERα either by selective …
target for more than 70% of all breast cancers (BCs). Antagonizing ERα either by selective …
Novel alkaloids from marine actinobacteria: discovery and characterization
AS De Rop, J Rombaut, T Willems, M De Graeve… - Marine Drugs, 2021 - mdpi.com
The marine environment is an excellent resource for natural products with therapeutic
potential. Its microbial inhabitants, often associated with other marine organisms, are …
potential. Its microbial inhabitants, often associated with other marine organisms, are …
Synthesis of Functionalized Isoquinolone Derivatives via Rh(III)-Catalyzed [4+2]-Annulation of Benzamides with Internal Acetylene-Containing α-CF3-α-Amino …
DV Vorobyeva, DA Petropavlovskikh, IA Godovikov… - Molecules, 2022 - mdpi.com
A convenient pathway to a new series of α-CF3-substituted α-amino acid derivatives bearing
pharmacophore isoquinolone core in their backbone has been developed. The method is …
pharmacophore isoquinolone core in their backbone has been developed. The method is …